OncoHost Launches PROphet NSCLC Cancer Test in the United States
Predictive blood test guides first-line treatment decisions for advanced unresectable non-small lung cancer patients OncoHost, a precision diagnostics company centered on predictive biomarker development for improved patient care, launched the official PROphet non-small cell lung…
Read More